NCT04943354Completed
Associations of Combinations of Single-nucleotide Polymorphisms in Women With Premature Ovarian Failure
Associations of Combinations of Single-nucleotide Polymorphisms and Behavioural Risk Factors With Non-communicable Diseases and Adverse Outcomes in Women With Premature Ovarian Failure
Source: ClinicalTrials.gov · Last updated 12 Mar 2024
Brief summary (registry, in English)
Research objective. \- To study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with non-communicable diseases and adverse outcomes in women with premature ovarian failure. Research objectives: * To study the associations between combinations of single-nucleotide polymorphisms and behavioural risk factors with heart rate disorders and adverse outcomes in women with premature ovarian failure * Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with stable STIs in women with premature ovarian failure. * Examine the associations between combinations of single nucleotide polymorphisms and behavioural risk factors with thrombomolia in women with premature ovarian failure * Study the associations between combinations of single nucleotide polymorphisms and behavioural risk factors and adverse cardiovascular outcomes in women with premature ovarian failure.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 238 (actual)
- First submitted
- 27 Nov 2020
- Start date
- 1 Sept 2020
- Primary completion date
- 3 Jun 2022
- Lead sponsor
- Ryazan State Medical University
- Diseases
- Coronary artery disease
- NCT number
- NCT04943354
What you commit to
- Study type: Interventional
- Participants enrolled: 238
- From 1 Sept 2020 to the primary completion date, 3 Jun 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- age over 45 years
Other
- male gender
Who the study is looking for
- women under 45 years old
- presence of premature ovarian insufficiency in the medical history
Age in the registry: - to 45 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sergey Vladimirovich Lopukhov Coordinator of this site? Confirm its status | Ryazan | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.